Home / CHD9 Knockout Cell Lines

CHD9 Knockout Cell Lines

Gene: CHD9

Official Full Name: chromodomain helicase DNA binding protein 9provided by HGNC

Gene Summary: Predicted to enable several functions, including ATP binding activity; ATP hydrolysis activity; and ATP-dependent activity, acting on DNA. Predicted to be involved in DNA duplex unwinding; chromatin looping; and chromatin remodeling. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO26131 CHD9 Knockout cell line (HeLa) Human CHD9 1:3~1:6 Negative Online Inquiry
KO26132 CHD9 Knockout cell line (HCT 116) Human CHD9 1:2~1:4 Negative Online Inquiry
KO26133 CHD9 Knockout cell line (HEK293) Human CHD9 1:3~1:6 Negative Online Inquiry
KO26134 CHD9 Knockout cell line (A549) Human CHD9 1:3~1:4 Negative Online Inquiry

Background

CHD9 Gene Knockout Cell Lines represent a pivotal advancement in cellular and molecular biology, specifically designed to elucidate the functions and downstream effects of the chromodomain helicase DNA binding protein 9 (CHD9). These genetically modified cell lines have been engineered through CRISPR-Cas9 technology to create precise deletions in the CHD9 gene, facilitating in-depth studies of its role in chromatin remodeling, gene expression regulation, and cellular responses to environmental stimuli.

The core mechanism of action involves the disruption of CHD9’s normal function, allowing researchers to observe the resultant phenotypic variations. By manipulating CHD9 expression levels, users can explore its impact on cellular processes such as proliferation, differentiation, and apoptosis. This enables the identification of potential pathways involved in diseases such as cancer, autoimmune disorders, and developmental anomalies, thereby providing valuable insights into targetable mechanisms for therapeutic intervention.

The scientific importance of CHD9 Gene Knockout Cell Lines extends into both research and clinical settings, where they are utilized for high-throughput screening, drug discovery, and biomarker identification. Compared to traditional knockout models, these cell lines offer a more cost-effective and efficient approach, allowing for rapid experimentation without the complexities associated with whole-organism models.

What sets our CHD9 Gene Knockout Cell Lines apart is their exceptional reliability and reproducibility, as they come with extensive validation studies demonstrating consistent knockout efficiency and functionality across multiple experiments. Additionally, we provide comprehensive technical support and detailed user protocols to ensure seamless integration into any laboratory workflow.

In summary, the CHD9 Gene Knockout Cell Lines are indispensable tools for researchers and clinicians seeking to deepen their understanding of gene function and disease mechanisms. Our commitment to excellence in product development and our expertise in genetic engineering position us as a leader in the field of biological products, ready to support your scientific endeavors.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.